Global Multiple Sclerosis Drugs Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 105 pages | ID: GC8558854E96EN
LP Information

Abstracts

According to this study, the global Multiple Sclerosis Drugs Treatment market size will reach US$ million by 2031.

Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of the course of disease as the characteristics, multiple sclerosis drug treatment can reduce the recurrence rate of this disease and slow down the process of disability.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Multiple Sclerosis Drugs Treatment Industry Forecast” looks at past sales and reviews total world Multiple Sclerosis Drugs Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Multiple Sclerosis Drugs Treatment sales for 2025 through 2031. With Multiple Sclerosis Drugs Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiple Sclerosis Drugs Treatment industry.

This Insight Report provides a comprehensive analysis of the global Multiple Sclerosis Drugs Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multiple Sclerosis Drugs Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multiple Sclerosis Drugs Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiple Sclerosis Drugs Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiple Sclerosis Drugs Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Multiple Sclerosis Drugs Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Interferon
• Immunomodulator
• Immunosuppressant

Segmentation by Application:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Roche
• Biogen
• Teva Pharmaceutical
• Merck
• Novartis
• Bayer
• Sanofi
• Acorda Therapeutics
• Questcor Pharmaceuticals
• AbbVie
• Opexa Therapeutics
• Genzyme Corporation

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Multiple Sclerosis Drugs Treatment Market Size (2020-2031)
  2.1.2 Multiple Sclerosis Drugs Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Multiple Sclerosis Drugs Treatment by Country/Region (2020, 2024 & 2031)
2.2 Multiple Sclerosis Drugs Treatment Segment by Type
  2.2.1 Interferon
  2.2.2 Immunomodulator
  2.2.3 Immunosuppressant
2.3 Multiple Sclerosis Drugs Treatment Market Size by Type
  2.3.1 Multiple Sclerosis Drugs Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2020-2025)
2.4 Multiple Sclerosis Drugs Treatment Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Online Pharmacy
  2.4.4 Other
2.5 Multiple Sclerosis Drugs Treatment Market Size by Application
  2.5.1 Multiple Sclerosis Drugs Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2020-2025)

3 MULTIPLE SCLEROSIS DRUGS TREATMENT MARKET SIZE BY PLAYER

3.1 Multiple Sclerosis Drugs Treatment Market Size Market Share by Player
  3.1.1 Global Multiple Sclerosis Drugs Treatment Revenue by Player (2020-2025)
  3.1.2 Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Multiple Sclerosis Drugs Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MULTIPLE SCLEROSIS DRUGS TREATMENT BY REGION

4.1 Multiple Sclerosis Drugs Treatment Market Size by Region (2020-2025)
4.2 Global Multiple Sclerosis Drugs Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Multiple Sclerosis Drugs Treatment Market Size Growth (2020-2025)
4.4 APAC Multiple Sclerosis Drugs Treatment Market Size Growth (2020-2025)
4.5 Europe Multiple Sclerosis Drugs Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Multiple Sclerosis Drugs Treatment Market Size by Country (2020-2025)
5.2 Americas Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025)
5.3 Americas Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Multiple Sclerosis Drugs Treatment Market Size by Region (2020-2025)
6.2 APAC Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025)
6.3 APAC Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2020-2025)
7.2 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025)
7.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Multiple Sclerosis Drugs Treatment by Region (2020-2025)
8.2 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MULTIPLE SCLEROSIS DRUGS TREATMENT MARKET FORECAST

10.1 Global Multiple Sclerosis Drugs Treatment Forecast by Region (2026-2031)
  10.1.1 Global Multiple Sclerosis Drugs Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Multiple Sclerosis Drugs Treatment Forecast
  10.1.3 APAC Multiple Sclerosis Drugs Treatment Forecast
  10.1.4 Europe Multiple Sclerosis Drugs Treatment Forecast
  10.1.5 Middle East & Africa Multiple Sclerosis Drugs Treatment Forecast
10.2 Americas Multiple Sclerosis Drugs Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Multiple Sclerosis Drugs Treatment Forecast
  10.2.2 Canada Market Multiple Sclerosis Drugs Treatment Forecast
  10.2.3 Mexico Market Multiple Sclerosis Drugs Treatment Forecast
  10.2.4 Brazil Market Multiple Sclerosis Drugs Treatment Forecast
10.3 APAC Multiple Sclerosis Drugs Treatment Forecast by Region (2026-2031)
  10.3.1 China Multiple Sclerosis Drugs Treatment Market Forecast
  10.3.2 Japan Market Multiple Sclerosis Drugs Treatment Forecast
  10.3.3 Korea Market Multiple Sclerosis Drugs Treatment Forecast
  10.3.4 Southeast Asia Market Multiple Sclerosis Drugs Treatment Forecast
  10.3.5 India Market Multiple Sclerosis Drugs Treatment Forecast
  10.3.6 Australia Market Multiple Sclerosis Drugs Treatment Forecast
10.4 Europe Multiple Sclerosis Drugs Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Multiple Sclerosis Drugs Treatment Forecast
  10.4.2 France Market Multiple Sclerosis Drugs Treatment Forecast
  10.4.3 UK Market Multiple Sclerosis Drugs Treatment Forecast
  10.4.4 Italy Market Multiple Sclerosis Drugs Treatment Forecast
  10.4.5 Russia Market Multiple Sclerosis Drugs Treatment Forecast
10.5 Middle East & Africa Multiple Sclerosis Drugs Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Multiple Sclerosis Drugs Treatment Forecast
  10.5.2 South Africa Market Multiple Sclerosis Drugs Treatment Forecast
  10.5.3 Israel Market Multiple Sclerosis Drugs Treatment Forecast
  10.5.4 Turkey Market Multiple Sclerosis Drugs Treatment Forecast
10.6 Global Multiple Sclerosis Drugs Treatment Forecast by Type (2026-2031)
10.7 Global Multiple Sclerosis Drugs Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Multiple Sclerosis Drugs Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Multiple Sclerosis Drugs Treatment Product Offered
  11.1.3 Pfizer Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Multiple Sclerosis Drugs Treatment Product Offered
  11.2.3 Roche Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 Biogen
  11.3.1 Biogen Company Information
  11.3.2 Biogen Multiple Sclerosis Drugs Treatment Product Offered
  11.3.3 Biogen Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Biogen Main Business Overview
  11.3.5 Biogen Latest Developments
11.4 Teva Pharmaceutical
  11.4.1 Teva Pharmaceutical Company Information
  11.4.2 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Product Offered
  11.4.3 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Teva Pharmaceutical Main Business Overview
  11.4.5 Teva Pharmaceutical Latest Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Multiple Sclerosis Drugs Treatment Product Offered
  11.5.3 Merck Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Merck Main Business Overview
  11.5.5 Merck Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Multiple Sclerosis Drugs Treatment Product Offered
  11.6.3 Novartis Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Bayer
  11.7.1 Bayer Company Information
  11.7.2 Bayer Multiple Sclerosis Drugs Treatment Product Offered
  11.7.3 Bayer Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Bayer Main Business Overview
  11.7.5 Bayer Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Multiple Sclerosis Drugs Treatment Product Offered
  11.8.3 Sanofi Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments
11.9 Acorda Therapeutics
  11.9.1 Acorda Therapeutics Company Information
  11.9.2 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Product Offered
  11.9.3 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Acorda Therapeutics Main Business Overview
  11.9.5 Acorda Therapeutics Latest Developments
11.10 Questcor Pharmaceuticals
  11.10.1 Questcor Pharmaceuticals Company Information
  11.10.2 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Product Offered
  11.10.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Questcor Pharmaceuticals Main Business Overview
  11.10.5 Questcor Pharmaceuticals Latest Developments
11.11 AbbVie
  11.11.1 AbbVie Company Information
  11.11.2 AbbVie Multiple Sclerosis Drugs Treatment Product Offered
  11.11.3 AbbVie Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 AbbVie Main Business Overview
  11.11.5 AbbVie Latest Developments
11.12 Opexa Therapeutics
  11.12.1 Opexa Therapeutics Company Information
  11.12.2 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Product Offered
  11.12.3 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Opexa Therapeutics Main Business Overview
  11.12.5 Opexa Therapeutics Latest Developments
11.13 Genzyme Corporation
  11.13.1 Genzyme Corporation Company Information
  11.13.2 Genzyme Corporation Multiple Sclerosis Drugs Treatment Product Offered
  11.13.3 Genzyme Corporation Multiple Sclerosis Drugs Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Genzyme Corporation Main Business Overview
  11.13.5 Genzyme Corporation Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Multiple Sclerosis Drugs Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Multiple Sclerosis Drugs Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Interferon
Table 4. Major Players of Immunomodulator
Table 5. Major Players of Immunosuppressant
Table 6. Multiple Sclerosis Drugs Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2020-2025)
Table 9. Multiple Sclerosis Drugs Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Multiple Sclerosis Drugs Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Player (2020-2025)
Table 14. Multiple Sclerosis Drugs Treatment Key Players Head office and Products Offered
Table 15. Multiple Sclerosis Drugs Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Multiple Sclerosis Drugs Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Multiple Sclerosis Drugs Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Multiple Sclerosis Drugs Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Multiple Sclerosis Drugs Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Multiple Sclerosis Drugs Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Multiple Sclerosis Drugs Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Multiple Sclerosis Drugs Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Multiple Sclerosis Drugs Treatment
Table 40. Key Market Challenges & Risks of Multiple Sclerosis Drugs Treatment
Table 41. Key Industry Trends of Multiple Sclerosis Drugs Treatment
Table 42. Global Multiple Sclerosis Drugs Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Multiple Sclerosis Drugs Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Multiple Sclerosis Drugs Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Multiple Sclerosis Drugs Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 47. Pfizer Multiple Sclerosis Drugs Treatment Product Offered
Table 48. Pfizer Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Roche Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 52. Roche Multiple Sclerosis Drugs Treatment Product Offered
Table 53. Roche Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Biogen Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 57. Biogen Multiple Sclerosis Drugs Treatment Product Offered
Table 58. Biogen Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Biogen Main Business
Table 60. Biogen Latest Developments
Table 61. Teva Pharmaceutical Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 62. Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Product Offered
Table 63. Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Teva Pharmaceutical Main Business
Table 65. Teva Pharmaceutical Latest Developments
Table 66. Merck Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 67. Merck Multiple Sclerosis Drugs Treatment Product Offered
Table 68. Merck Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Merck Main Business
Table 70. Merck Latest Developments
Table 71. Novartis Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 72. Novartis Multiple Sclerosis Drugs Treatment Product Offered
Table 73. Novartis Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76. Bayer Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 77. Bayer Multiple Sclerosis Drugs Treatment Product Offered
Table 78. Bayer Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bayer Main Business
Table 80. Bayer Latest Developments
Table 81. Sanofi Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 82. Sanofi Multiple Sclerosis Drugs Treatment Product Offered
Table 83. Sanofi Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sanofi Main Business
Table 85. Sanofi Latest Developments
Table 86. Acorda Therapeutics Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 87. Acorda Therapeutics Multiple Sclerosis Drugs Treatment Product Offered
Table 88. Acorda Therapeutics Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Acorda Therapeutics Main Business
Table 90. Acorda Therapeutics Latest Developments
Table 91. Questcor Pharmaceuticals Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 92. Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Product Offered
Table 93. Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Questcor Pharmaceuticals Main Business
Table 95. Questcor Pharmaceuticals Latest Developments
Table 96. AbbVie Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 97. AbbVie Multiple Sclerosis Drugs Treatment Product Offered
Table 98. AbbVie Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. AbbVie Main Business
Table 100. AbbVie Latest Developments
Table 101. Opexa Therapeutics Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 102. Opexa Therapeutics Multiple Sclerosis Drugs Treatment Product Offered
Table 103. Opexa Therapeutics Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Opexa Therapeutics Main Business
Table 105. Opexa Therapeutics Latest Developments
Table 106. Genzyme Corporation Details, Company Type, Multiple Sclerosis Drugs Treatment Area Served and Its Competitors
Table 107. Genzyme Corporation Multiple Sclerosis Drugs Treatment Product Offered
Table 108. Genzyme Corporation Multiple Sclerosis Drugs Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Genzyme Corporation Main Business
Table 110. Genzyme Corporation Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Multiple Sclerosis Drugs Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Multiple Sclerosis Drugs Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Multiple Sclerosis Drugs Treatment Sales Market Share by Country/Region (2024)
Figure 8. Multiple Sclerosis Drugs Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Type in 2024
Figure 10. Multiple Sclerosis Drugs Treatment in Hospital Pharmacy
Figure 11. Global Multiple Sclerosis Drugs Treatment Market: Hospital Pharmacy (2020-2025) & ($ millions)
Figure 12. Multiple Sclerosis Drugs Treatment in Retail Pharmacy
Figure 13. Global Multiple Sclerosis Drugs Treatment Market: Retail Pharmacy (2020-2025) & ($ millions)
Figure 14. Multiple Sclerosis Drugs Treatment in Online Pharmacy
Figure 15. Global Multiple Sclerosis Drugs Treatment Market: Online Pharmacy (2020-2025) & ($ millions)
Figure 16. Multiple Sclerosis Drugs Treatment in Other
Figure 17. Global Multiple Sclerosis Drugs Treatment Market: Other (2020-2025) & ($ millions)
Figure 18. Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Application in 2024
Figure 19. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Player in 2024
Figure 20. Global Multiple Sclerosis Drugs Treatment Market Size Market Share by Region (2020-2025)
Figure 21. Americas Multiple Sclerosis Drugs Treatment Market Size 2020-2025 ($ millions)
Figure 22. APAC Multiple Sclerosis Drugs Treatment Market Size 2020-2025 ($ millions)
Figure 23. Europe Multiple Sclerosis Drugs Treatment Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size 2020-2025 ($ millions)
Figure 25. Americas Multiple Sclerosis Drugs Treatment Value Market Share by Country in 2024
Figure 26. United States Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Multiple Sclerosis Drugs Treatment Market Size Market Share by Region in 2024
Figure 31. APAC Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2020-2025)
Figure 32. APAC Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2020-2025)
Figure 33. China Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. India Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Country in 2024
Figure 40. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2020-2025)
Figure 41. Europe Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2020-2025)
Figure 42. Germany Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. France Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Multiple Sclerosis Drugs Treatment Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 56. APAC Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 57. Europe Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 59. United States Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 60. Canada Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 61. Mexico Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 62. Brazil Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 63. China Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 64. Japan Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 65. Korea Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 67. India Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 68. Australia Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 69. Germany Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 70. France Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 71. UK Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 72. Italy Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 73. Russia Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 74. Egypt Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 75. South Africa Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 76. Israel Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 77. Turkey Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)
Figure 78. Global Multiple Sclerosis Drugs Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Multiple Sclerosis Drugs Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Multiple Sclerosis Drugs Treatment Market Size 2026-2031 ($ millions)